BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6405026)

  • 1. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
    Gregus Z; Watkins JB; Thompson TN; Klaassen CD
    J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
    Gregus Z; Madhu C; Goon D; Klaassen CD
    Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of butylated hydroxyanisole on hepatic glucuronidation and biliary excretion of drugs in mice.
    Gregus Z; Klaassen CD
    J Pharm Pharmacol; 1988 Apr; 40(4):237-42. PubMed ID: 2900301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
    Watkins JB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat.
    Kamisako T; Adachi Y; Yamamoto T
    J Pharmacol Exp Ther; 1990 Aug; 254(2):380-2. PubMed ID: 2384879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of uridine diphosphoglucuronic acid on bilirubin glucuronidation in liver microsomes from normal and spironolactone-treated rats.
    Mottino AD; Rodríguez Garay EA
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):479-84. PubMed ID: 3152590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
    Watkins JB; Klaassen CD
    Drug Metab Dispos; 1985; 13(2):186-91. PubMed ID: 2859166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosamine prevents ethinylestradiol-induced cholestasis.
    Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
    Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically-induced alteration of UDP-glucuronic acid concentration in rat liver.
    Watkins JB; Klaassen CD
    Drug Metab Dispos; 1983; 11(1):37-40. PubMed ID: 6132793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion of organic anions in diabetic rats.
    Watkins JB; Noda H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):467-73. PubMed ID: 2430094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.
    Yamamura N; Imura-Miyoshi K; Naganuma H
    Drug Metab Dispos; 2000 Dec; 28(12):1484-6. PubMed ID: 11095587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated.
    Howell SR; Hazelton GA; Klaassen CD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):610-4. PubMed ID: 3081704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous uridine diphosphoglucuronic acid breakdown in rat small intestinal mucosa preparations. Effect of other nucleotides.
    Mottino AD; Denoya O; Rodríguez Garay EA
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):455-8. PubMed ID: 4059659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of UDPGA flux in acetaminophen clearance and hepatotoxicity.
    Price VF; Jollow DJ
    Xenobiotica; 1984 Jul; 14(7):553-9. PubMed ID: 6438923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inhibitors of mitochondrial energy production on hepatic glutathione, UDP-glucuronic acid, and adenosine 3'-phosphate-5'-phosphosulfate concentrations.
    Dills RL; Klaassen CD
    Drug Metab Dispos; 1986; 14(2):190-6. PubMed ID: 2870893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.
    Hjelle JJ; Hazelton GA; Klaassen CD
    Drug Metab Dispos; 1985; 13(1):35-41. PubMed ID: 2858374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reduced hepatic energy state on acetaminophen conjugation in rats.
    Dills RL; Klaassen CD
    J Pharmacol Exp Ther; 1986 Aug; 238(2):463-72. PubMed ID: 3735128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of temporary occlusion of the superior mesenteric vein or splenic vein on biliary bilirubin and bile acid excretion in rats.
    Adachi Y; Kamisako T; Yamamoto T
    J Lab Clin Med; 1991 Sep; 118(3):261-8. PubMed ID: 1919299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.